Journal ArticleDOI
Pilot study assessing the use of cabergoline for the treatment of cats with hypersomatotropism and diabetes mellitus
Christopher J Scudder,Katarina Hazuchova,Ruth Gostelow,David B. Church,Yaiza Forcada,Robert C. Fowkes,Stijn J. M. Niessen,Stijn J. M. Niessen +7 more
TLDR
Cabergoline did not improve diabetic control or normalise insulin-like growth factor concentration, or improve patient quality of life.Abstract:
ObjectivesAn affordable and effective treatment is needed to manage feline hypersomatotropism. The aim of this study was to assess whether treatment with oral cabergoline for 90 days in cats with h...read more
Citations
More filters
Journal ArticleDOI
Diabetes mellitus remission in three cats with hypersomatotropism after cabergoline treatment
D. D. Miceli,D. D. Miceli,Patricia Noemi Vidal,Gustavo A Pompili,Víctor Castillo,Elber Alberto Soler Arias,Stijn Jm Niessen +6 more
TL;DR: Miceli et al. as mentioned in this paper presented a study on the use of biomaterials in the field of biologia and medicine in the context of biomedical research in the country of Argentina, with the support of the Fundación de Instituto de Biologia y Medicina Experimental.
Journal ArticleDOI
Pituitary tumour types in dogs and cats.
TL;DR: An overview of the different pituitary tumour types in dogs and cats that have been reported in the literature can be found in this paper, where the authors provide a review of the most common Pituitary adenoma types in humans and dogs.
Journal ArticleDOI
Quality of life and response to treatment in cats with hypersomatotropism: the owners’ point of view
TL;DR: In this article , the authors collected clinical information from owners of cats with hypersomatotropism (HS) distributed worldwide, assessing the impact of HS and its treatments on cats' quality of life (QoL) and survival time.
Journal ArticleDOI
Cabergoline treatment in cats with diabetes mellitus and hypersomatotropism
TL;DR: In this article , the authors evaluated the safety and efficacy of cabergoline to control hypersomatotropism (HST) and diabetes mellitus (DM) in cats.
Journal ArticleDOI
Cabergoline treatment in cats with diabetes mellitus and hypersomatotropism
D. D. Miceli,Jorge Daniel García,G. Pompili,Juan P Rey Amunategui,S. Ferraris,Omar Pedro Pignataro,Mirtha Guitelman +6 more
TL;DR: Cabergoline improved diabetes control and was associated with remission of DM in 35% of cases and could be a treatment option for cats with HST and DM, especially in those cases with a relatively small pituitary tumor.
References
More filters
Journal ArticleDOI
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
TL;DR: D dopamine receptor classification, their basic structural and genetic organization, their distribution and functions in the brain and the periphery, and their regulation and signal transduction mechanisms are discussed.
Journal ArticleDOI
Acromegaly: An Endocrine Society Clinical Practice Guideline
Laurence Katznelson,Edward R. Laws,Shlomo Melmed,Mark E. Molitch,Mohammad Hassan Murad,Andrea L. Utz,John A.H. Wass +6 more
TL;DR: This evidence-based guideline addresses important clinical issues regarding the evaluation and management of acromegaly, including the appropriate biochemical assessment, a therapeutic algorithm, including use of medical monotherapy or combination therapy, and management during pregnancy.
Journal ArticleDOI
Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline
Shlomo Melmed,Felipe F. Casanueva,Andrew R. Hoffman,David L. Kleinberg,Victor M. Montori,Janet A. Schlechte,John A.H. Wass +6 more
TL;DR: This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe both the strength of recommendations and the quality of evidence for diagnosis and treatment of hyperprolactinemia.
Journal ArticleDOI
Measuring quality of life: Using quality of life measures in the clinical setting.
Irene J Higginson,Alison Carr +1 more
TL;DR: This article reviews the challenges of using quality of life measures in clinical practice including selecting appropriate measures, analysing data, providing feedback, interpreting results, and incorporating these measures into clinical decision making.
Journal ArticleDOI
Dopamine agonists and the risk of cardiac-valve regurgitation.
TL;DR: Use of the dopamine agonists pergolide and cabergoline was associated with an increased risk of newly diagnosed cardiac-valve regurgitation.